WHO ICTRP trial

Efficacy of MahÄ?paiÅ?acika GhÅ?ta against KÅ«Å?maÅ?Ä?a GhÅ?ta in Attention…

CTRI/2023/05/053180 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2023/05/053180
Public title Efficacy of MahÄ?paiÅ?acika GhÅ?ta against KÅ«Å?maÅ?Ä?a GhÅ?ta in Attention - Deficit/Hyperactivity Disorder
Scientific title Efficacy of MahÄ?paiÅ?acika GhÅ?ta against KÅ«Å?maÅ?Ä?a GhÅ?ta in Attention â??Deficit /Hyperactivity Disorder â?? A Non-Inferiority Randomized Controlled Trial
Primary sponsor Shifa Aboobacker V
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Registration date May 29, 2023
Target size 22
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations